ZA974546B - Medicinal aerosol formulations of formoterol - Google Patents
Medicinal aerosol formulations of formoterolInfo
- Publication number
- ZA974546B ZA974546B ZA974546A ZA974546A ZA974546B ZA 974546 B ZA974546 B ZA 974546B ZA 974546 A ZA974546 A ZA 974546A ZA 974546 A ZA974546 A ZA 974546A ZA 974546 B ZA974546 B ZA 974546B
- Authority
- ZA
- South Africa
- Prior art keywords
- formoterol
- aerosol formulations
- medicinal aerosol
- medicinal
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9612297.3A GB9612297D0 (en) | 1996-06-11 | 1996-06-11 | Medicinal aerosol formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA974546B true ZA974546B (en) | 1998-11-23 |
Family
ID=10795182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA974546A ZA974546B (en) | 1996-06-11 | 1997-05-23 | Medicinal aerosol formulations of formoterol |
Country Status (16)
Country | Link |
---|---|
EP (2) | EP1400239A1 (es) |
JP (1) | JP5000793B2 (es) |
AR (1) | AR009231A1 (es) |
AT (1) | ATE275940T1 (es) |
AU (1) | AU726382B2 (es) |
CA (1) | CA2257841C (es) |
DE (1) | DE69730723T2 (es) |
DK (1) | DK0934057T3 (es) |
ES (1) | ES2229366T3 (es) |
GB (1) | GB9612297D0 (es) |
ID (1) | ID19520A (es) |
NO (1) | NO320403B1 (es) |
NZ (1) | NZ333202A (es) |
PT (1) | PT934057E (es) |
WO (1) | WO1997047286A1 (es) |
ZA (1) | ZA974546B (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054488A (en) * | 1996-06-11 | 2000-04-25 | 3M Innovative Properties Company | Medicinal aerosol formulations of formoterol |
GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
US6423298B2 (en) * | 1998-06-18 | 2002-07-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pharmaceutical formulations for aerosols with two or more active substances |
US6451285B2 (en) | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
CZ20011362A3 (cs) * | 1998-10-17 | 2001-09-12 | Boehringer Ingelheim Pharma Kg | Skladovatelný koncentrát účinné látky s formoterolem |
DE19847969A1 (de) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Lagerfähig flüssige Formulierung mit Formoterol |
IT1303788B1 (it) * | 1998-11-25 | 2001-02-23 | Chiesi Farma Spa | Formulazioni di aerosol medicinali. |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
US6004537A (en) * | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
US6290930B1 (en) | 1998-12-18 | 2001-09-18 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide |
IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
JP5392880B2 (ja) | 2000-05-22 | 2014-01-22 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | 加圧式定量吸入器のための安定な製薬学的溶液製剤 |
SE0004750D0 (sv) * | 2000-12-19 | 2000-12-19 | Astrazeneca Ab | Novel formulation |
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
TR200401980T4 (tr) | 2001-07-02 | 2004-09-21 | Chiesi Farmaceutici S.P.A. | Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu |
AR036358A1 (es) * | 2001-08-28 | 2004-09-01 | Schering Corp | Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma |
GB0207899D0 (en) * | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and cielesonide aerosol formulations |
GB0207906D0 (en) * | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and mometasone aerosol formulations |
PT1542904E (pt) * | 2002-08-27 | 2008-03-24 | Schering Corp | Processo para produzir formulações para inaladores doseadores |
AU2004246819A1 (en) * | 2003-06-13 | 2004-12-23 | Nycomed Gmbh | Formoterol and ciclesonide combination |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
EP1925293A3 (en) * | 2003-10-20 | 2010-01-13 | Schering Corporation | Pharmaceutical aerosol compositions |
AU2004285447A1 (en) * | 2003-10-20 | 2005-05-12 | Schering Corporation | Pharmaceutical compositions |
EP1595531A1 (en) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
MX2009004198A (es) * | 2006-10-17 | 2009-10-19 | Lithera Inc | Metodos, composiciones y formulaciones para el tratamiento de enfermedad ocular tiroidea. |
ES2774391T3 (es) | 2009-05-29 | 2020-07-20 | Pearl Therapeutics Inc | Composiciones, métodos y sistemas para la administración respiratoria de dos o más agentes activos |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
ME02398B (me) * | 2009-10-02 | 2016-09-20 | Chiesi Farm Spa | Farmaceutske aerosolne formulacije formoterola i beklometazon dipropionata |
RU2696582C2 (ru) | 2013-03-15 | 2019-08-05 | Перл Терапьютикс, Инк. | Способы и системы кондиционирования дисперсных кристаллических материалов |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5194990A (en) * | 1989-02-23 | 1990-09-26 | Rorer International (Holdings), Inc. | Therapeutic aerosol formulations |
IL97065A (en) * | 1990-02-02 | 1994-01-25 | Fisons Plc | Repellent preparations for aerosol |
GB9024365D0 (en) * | 1990-11-09 | 1991-01-02 | Glaxo Group Ltd | Medicaments |
EP0504112A3 (en) * | 1991-03-14 | 1993-04-21 | Ciba-Geigy Ag | Pharmaceutical aerosol formulations |
ES2158910T3 (es) * | 1991-06-10 | 2001-09-16 | Schering Corp | Formulaciones en aerosol sin clorofluorocarbonos. |
EP0587790B2 (en) * | 1991-06-10 | 2000-03-08 | Schering Corporation | Non-chlorofluorocarbon aerosol formulations |
EP0616525B1 (en) * | 1991-12-12 | 1995-09-27 | Glaxo Group Limited | Pharmaceutical aerosol formulation |
IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
DE69233319T2 (de) * | 1991-12-18 | 2005-02-17 | Minnesota Mining & Manufacturing Company, St. Paul | Aerosolzusammensetzungen für Arzneimittelsuspensionen |
GB9207400D0 (en) * | 1992-04-02 | 1992-05-13 | Smithkline Beecham Plc | Novel use |
US5354934A (en) * | 1993-02-04 | 1994-10-11 | Amgen Inc. | Pulmonary administration of erythropoietin |
GB9425160D0 (en) * | 1994-12-10 | 1995-02-08 | Glaxo Group Ltd | Medicaments |
GB9426252D0 (en) * | 1994-12-24 | 1995-02-22 | Glaxo Group Ltd | Pharmaceutical composition |
-
1996
- 1996-06-11 GB GBGB9612297.3A patent/GB9612297D0/en active Pending
-
1997
- 1997-05-23 ZA ZA974546A patent/ZA974546B/xx unknown
- 1997-06-02 JP JP50165698A patent/JP5000793B2/ja not_active Expired - Lifetime
- 1997-06-02 CA CA002257841A patent/CA2257841C/en not_active Expired - Lifetime
- 1997-06-02 AU AU33739/97A patent/AU726382B2/en not_active Expired
- 1997-06-02 EP EP03014565A patent/EP1400239A1/en not_active Withdrawn
- 1997-06-02 PT PT97929756T patent/PT934057E/pt unknown
- 1997-06-02 DK DK97929756T patent/DK0934057T3/da active
- 1997-06-02 AT AT97929756T patent/ATE275940T1/de not_active IP Right Cessation
- 1997-06-02 DE DE69730723T patent/DE69730723T2/de not_active Expired - Lifetime
- 1997-06-02 EP EP97929756A patent/EP0934057B1/en not_active Expired - Lifetime
- 1997-06-02 NZ NZ333202A patent/NZ333202A/en not_active IP Right Cessation
- 1997-06-02 WO PCT/US1997/009471 patent/WO1997047286A1/en active IP Right Grant
- 1997-06-02 ES ES97929756T patent/ES2229366T3/es not_active Expired - Lifetime
- 1997-06-04 AR ARP970102437A patent/AR009231A1/es unknown
- 1997-06-09 ID IDP971970A patent/ID19520A/id unknown
-
1998
- 1998-12-07 NO NO19985720A patent/NO320403B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
NZ333202A (en) | 2000-06-23 |
ATE275940T1 (de) | 2004-10-15 |
EP1400239A1 (en) | 2004-03-24 |
JP2000513340A (ja) | 2000-10-10 |
PT934057E (pt) | 2004-12-31 |
NO985720L (no) | 1999-02-11 |
GB9612297D0 (en) | 1996-08-14 |
DE69730723D1 (de) | 2004-10-21 |
DK0934057T3 (da) | 2005-01-24 |
AU3373997A (en) | 1998-01-07 |
EP0934057A1 (en) | 1999-08-11 |
EP0934057B1 (en) | 2004-09-15 |
AR009231A1 (es) | 2000-04-12 |
ES2229366T3 (es) | 2005-04-16 |
JP5000793B2 (ja) | 2012-08-15 |
DE69730723T2 (de) | 2005-10-06 |
NO320403B1 (no) | 2005-11-28 |
NO985720D0 (no) | 1998-12-07 |
ID19520A (id) | 1998-07-16 |
CA2257841A1 (en) | 1997-12-18 |
WO1997047286A1 (en) | 1997-12-18 |
CA2257841C (en) | 2008-05-20 |
AU726382B2 (en) | 2000-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA974546B (en) | Medicinal aerosol formulations of formoterol | |
IL116460A0 (en) | Aerosol drug formulations | |
ZA975883B (en) | High dose liposomal aerosol formulations | |
HUP0000795A3 (en) | Medicinal aerosol formulations comprising budesonide | |
GB9408117D0 (en) | Pharmaceutical formulations | |
HUT77377A (hu) | Aeroszol készítmények | |
GB9404248D0 (en) | Pharmaceutical formulations | |
PL348975A1 (en) | Pharmaceutical aerosol formulations containing fluoroalkanes and budesonide | |
EG21177A (en) | Insecticidal aerosol composition and insecticidal composition for preparation of same | |
IL128714A (en) | Chlorofluorocarbon-free mometasone furoate aerosol formulations | |
AU1847695A (en) | Pharmaceutical formulations of cntf | |
IL112897A0 (en) | Aerosol drug formulations containing vitamin e | |
GB9304745D0 (en) | Use of pharmaceutical formulations | |
GB9413542D0 (en) | Pharmaceutical formulations | |
ZA9510754B (en) | Aerosol drug formulations | |
ZA976038B (en) | Medicinal aerosol solution formulation | |
ZA956970B (en) | Improved pharmaceutical formulations their preparation and use | |
GB9408162D0 (en) | Pharmaceutical formulations | |
GB9408161D0 (en) | Pharmaceutical formulations | |
GB9408164D0 (en) | Pharmaceutical formulations | |
GB9408163D0 (en) | Pharmaceutical formulations | |
GB9417953D0 (en) | Pharmaceutical formulations | |
GB9414216D0 (en) | Pharmaceutical formulations | |
GB9401738D0 (en) | Pharmaceutical formulations | |
GB9426113D0 (en) | Pharmaceutical formulations |